A neurotoxic regimen of methamphetamine exacerbates the febrile and neuroinflammatory response to a subsequent peripheral immune stimulus

Journal of Neuroinflammation

Volumn 7, Issue , 2010, Pages

  Buchanan, Jessica B ^a   Sparkman, Nathan L ^a   Johnson, Rodney W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; METHAMPHETAMINE; PROTEIN LBA1; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AIF1 PROTEIN, MOUSE; CALCIUM BINDING PROTEIN; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BRAIN LEVEL; BRAIN TISSUE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE EXACERBATION; ENCEPHALITIS; FEVER; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATION; MALE; MICROGLIA; MOUSE; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THERMOREGULATION; ANIMAL; BLOOD; BODY TEMPERATURE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM; MOTOR ACTIVITY;

ANIMALS; BODY TEMPERATURE; CALCIUM-BINDING PROTEINS; CYTOKINES; FEVER; LIPOPOLYSACCHARIDES; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICROGLIA; MOTOR ACTIVITY; RNA, MESSENGER;

EID: 78549255942     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-7-82     Document Type: Article

References (41)

1. Halkitis PN, Parsons JT, Stirratt MJ. A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. J Homosex 2001, 41(2):17-35. 10.1300/J082v41n02_02, 11482426.
2. Purcell DW, Parsons JT, Halkitis PN, Mizuno Y, Woods WJ. Substance use and sexual transmission risk behavior of HIV-positive men who have sex with men. J Subst Abuse 2001, 13(1-2):185-200. 10.1016/S0899-3289(01)00072-4, 11547619.
3. Gonzales R, Marinelli-Casey P, Shoptaw S, Ang A, Rawson RA. Hepatitis C virus infection among methamphetamine-dependent individuals in outpatient treatment. J Subst Abuse Treat 2006, 31(2):195-202. 10.1016/j.jsat.2006.04.006, 16919748.
4. Miller CL, Kerr T, Fischer B, Zhang R, Wood E. Methamphetamine injection independently predicts hepatitis C infection among street-involved youth in a Canadian setting. J Adolesc Health 2009, 44(3):302-304. 10.1016/j.jadohealth.2008.08.007, 19237118.
5. Cadet JL, Jayanthi S, Deng X. Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. Faseb J 2003, 17(13):1775-1788. 10.1096/fj.03-0073rev, 14519657.
6. Yamamoto BK, Moszczynska A, Gudelsky GA. Amphetamine toxicities: classical and emerging mechanisms. Ann N Y Acad Sci 2010, 1187:101-121. 10.1111/j.1749-6632.2009.05141.x, 20201848.
7. Thomas DM, Walker PD, Benjamins JA, Geddes TJ, Kuhn DM. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J Pharmacol Exp Ther 2004, 311(1):1-7. 10.1124/jpet.104.070961, 15163680.
8. Riddle EL, Fleckenstein AE, Hanson GR. Mechanisms of methamphetamine-induced dopaminergic neurotoxicity. Aaps J 2006, 8(2):E413-418.
9. Sekine Y, Ouchi Y, Sugihara G, Takei N, Yoshikawa E, Nakamura K, Iwata Y, Tsuchiya KJ, Suda S, Suzuki K, et al. Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci 2008, 28(22):5756-5761. 10.1523/JNEUROSCI.1179-08.2008, 2491906, 18509037.
10. Goncalves J, Baptista S, Martins T, Milhazes N, Borges F, Ribeiro CF, Malva JO, Silva AP. Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin. Eur J Neurosci 2010, 31(2):315-326. 10.1111/j.1460-9568.2009.07059.x, 20074221.
11. Fantegrossi WE, Ciullo JR, Wakabayashi KT, De La Garza R, Traynor JR, Woods JH. A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse. Neuroscience 2008, 151(2):533-543. 10.1016/j.neuroscience.2007.11.007, 2276981, 18082974.
12. Hozumi H, Asanuma M, Miyazaki I, Fukuoka S, Kikkawa Y, Kimoto N, Kitamura Y, Sendo T, Kita T, Gomita Y. Protective effects of interferon-gamma against methamphetamine-induced neurotoxicity. Toxicol Lett 2008, 177(2):123-129. 10.1016/j.toxlet.2008.01.005, 18282668.
13. Thomas DM, Kuhn DM. Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine. J Neurochem 2005, 92(4):790-797. 10.1111/j.1471-4159.2004.02906.x, 15686480.
14. Flora G, Lee YW, Nath A, Hennig B, Maragos W, Toborek M. Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain. Exp Neurol 2003, 179(1):60-70. 10.1006/exnr.2002.8048, 12504868.
15. Nakajima A, Yamada K, Nagai T, Uchiyama T, Miyamoto Y, Mamiya T, He J, Nitta A, Mizuno M, Tran MH, et al. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity. J Neurosci 2004, 24(9):2212-2225. 10.1523/JNEUROSCI.4847-03.2004, 14999072.
16. Numachi Y, Ohara A, Yamashita M, Fukushima S, Kobayashi H, Hata H, Watanabe H, Hall FS, Lesch KP, Murphy DL, et al. Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. Eur J Pharmacol 2007, 572(2-3):120-128. 10.1016/j.ejphar.2007.06.022, 17673199.
17. Halladay AK, Kusnecov A, Michna L, Kita T, Hara C, Wagner GC. Relationship between methamphetamine-induced dopamine release, hyperthermia, self-injurious behaviour and long term dopamine depletion in BALB/c and C57BL/6 mice. Pharmacol Toxicol 2003, 93(1):33-41. 10.1034/j.1600-0773.2003.930105.x, 12828572.
18. Lai YT, Tsai YP, Cherng CG, Ke JJ, Ho MC, Tsai CW, Yu L. Lipopolysaccharide mitagates methamphetamine-induced striatal dopamine depletion via modulating local TNF-alpha and dopamine transporter expression. J Neural Transm 2009, 116(4):405-415. 10.1007/s00702-009-0204-2, 19271121.
19. Saito M, Terada M, Kawata T, Ito H, Shigematsu N, Kromkhun P, Yokosuka M, Saito TR. Effects of single or repeated administrations of methamphetamine on immune response in mice. Exp Anim 2008, 57(1):35-43. 10.1538/expanim.57.35, 18256517.
20. Yu Q, Montes S, Larson DF, Watson RR. Effects of chronic methamphetamine exposure on heart function in uninfected and retrovirus-infected mice. Life Sci 2002, 71(8):953-965. 10.1016/S0024-3205(02)01769-1, 12084392.
21. Martinez LR, Mihu MR, Gacser A, Santambrogio L, Nosanchuk JD. Methamphetamine enhances histoplasmosis by immunosuppression of the host. J Infect Dis 2009, 200(1):131-141. 10.1086/599328, 19473099.
22. In SW, Son EW, Rhee DK, Pyo S. Methamphetamine administration produces immunomodulation in mice. J Toxicol Environ Health A 2005, 68(23-24):2133-2145. 10.1080/15287390500177156, 16326429.
23. Maier SF, Goehler LE, Fleshner M, Watkins LR. The role of the vagus nerve in cytokine-to-brain communication. Ann N Y Acad Sci 1998, 840:289-300. 10.1111/j.1749-6632.1998.tb09569.x, 9629257.
24. Rivest S. Molecular insights on the cerebral innate immune system. Brain Behav Immun 2003, 17(1):13-19. 10.1016/S0889-1591(02)00055-7, 12615045.
25. Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 2005, 76(2):77-98. 10.1016/j.pneurobio.2005.06.004, 16081203.
26. Buchanan JB, Sparkman NL, Johnson RW. Methamphetamine sensitization attenuates the febrile and neuroinflammatory response to a subsequent peripheral immune stimulus. Brain Behav Immun 2010, 24(3):502-511. 10.1016/j.bbi.2009.12.008, 20035859.
27. Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res 1998, 57(1):1-9. 10.1016/S0169-328X(98)00040-0, 9630473.
28. Ito D, Tanaka K, Suzuki S, Dembo T, Fukuuchi Y. Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke 2001, 32(5):1208-1215.
29. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55(5):453-462. 10.1002/glia.20467, 2871685, 17203472.
30. Sandhir R, Onyszchuk G, Berman NE. Exacerbated glial response in the aged mouse hippocampus following controlled cortical impact injury. Exp Neurol 2008, 213(2):372-380. 10.1016/j.expneurol.2008.06.013, 2662478, 18692046.
31. Graham DL, Noailles PA, Cadet JL. Differential neurochemical consequences of an escalating dose-binge regimen followed by single-day multiple-dose methamphetamine challenges. J Neurochem 2008, 105(5):1873-1885. 10.1111/j.1471-4159.2008.05269.x, 18248616.
32. Danaceau JP, Deering CE, Day JE, Smeal SJ, Johnson-Davis KL, Fleckenstein AE, Wilkins DG. Persistence of tolerance to methamphetamine-induced monoamine deficits. Eur J Pharmacol 2007, 559(1):46-54. 10.1016/j.ejphar.2006.11.045, 17239369.
33. Cadet JL, Krasnova IN, Ladenheim B, Cai NS, McCoy MT, Atianjoh FE. Methamphetamine preconditioning: differential protective effects on monoaminergic systems in the rat brain. Neurotox Res 2009, 15(3):252-259. 10.1007/s12640-009-9026-0, 2673017, 19384598.
34. Stephans S, Yamamoto B. Methamphetamines pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity. Neuroscience 1996, 72(3):593-600. 10.1016/0306-4522(95)00587-0, 8861054.
35. Johnson-Davis KL, Fleckenstein AE, Wilkins DG. The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity. Eur J Pharmacol 2003, 482(1-3):151-154. 10.1016/j.ejphar.2003.09.063, 14660016.
36. Thomas DM, Dowgiert J, Geddes TJ, Francescutti-Verbeem D, Liu X, Kuhn DM. Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines. Neurosci Lett 2004, 367(3):349-354. 10.1016/j.neulet.2004.06.065, 15337264.
37. Sriram K, Miller DB, O'Callaghan JP. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. J Neurochem 2006, 96(3):706-718. 10.1111/j.1471-4159.2005.03566.x, 16405514.
38. Buchanan JB, Peloso E, Satinoff E. Influence of ambient temperature on peripherally induced interleukin-1 beta fever in young and old rats. Physiol Behav 2006, 88(4-5):453-458. 10.1016/j.physbeh.2006.04.012, 16762379.
39. Plata-Salaman CR, Peloso E, Satinoff E. Interleukin-1beta-induced fever in young and old Long-Evans rats. Am J Physiol 1998, 275(5 Pt 2):R1633-1638.
40. Cartmell T, Luheshi GN, Rothwell NJ. Brain sites of action of endogenous interleukin-1 in the febrile response to localized inflammation in the rat. J Physiol 1999, 518(Pt 2):585-594. 10.1111/j.1469-7793.1999.0585p.x, 2269440, 10381603.
41. Luheshi G, Miller AJ, Brouwer S, Dascombe MJ, Rothwell NJ, Hopkins SJ. Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat. Am J Physiol 1996, 270(1 Pt 1):E91-95.